What prices were used for Laura Hamill’s JAZZ tax-withholding share dispositions?

The filing reports 14 shares at $244.0643 per share and 1,692 shares at $241.3900 per share, both designated as payment of tax liability by delivering or withholding securities.

Jazz Pharma director withholds 1,706 shares for tax

Q: What insider transaction did JAZZ director Laura Hamill report?

Director Laura Hamill reported two dispositions of ordinary shares on August 31, 2026, totaling 1,706 shares, to satisfy tax obligations related to the vesting of previously granted restricted stock units.

Q: Were the JAZZ insider transactions open-market sales?

No. The filing states that the 1,706 shares were sold to satisfy tax obligations from the vesting of restricted stock units, indicating tax-withholding dispositions rather than discretionary open-market sales.

Q: How many JAZZ shares did the director dispose of to cover RSU taxes?

In total, 1,706 ordinary shares of Jazz Pharmaceuticals were delivered or withheld on August 31, 2026 to cover tax obligations arising from the vesting of previously granted restricted stock units.

Q: Was a Rule 10b5-1 trading plan involved in these JAZZ transactions?

No. The document-level indicator for Rule 10b5-1 plans is marked false, meaning these reported tax-withholding dispositions were not affirmed as made under a Rule 10b5-1 trading plan.

A Jazz Pharmaceuticals director disposed of shares to cover taxes on vested restricted stock units, not through open-market sales.

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) reported insider activity by director Laura Hamill involving dispositions of ordinary shares on August 31, 2026. Two transactions totaling 1,706 shares were delivered or withheld to pay tax obligations arising from the vesting of previously granted restricted stock units, rather than open-market sales. No Rule 10b5-1 trading plan is reported for these transactions.

Insider Trade Summary

Tax Withholding: 1,706 shares

Tax Withholding 2 txns

Insider Hamill Laura

Role Director

Type	Security	Shares	Price	Value
Tax Withholding	Ordinary Shares ^F1	14	$244.0643	$3K
Tax Withholding	Ordinary Shares ^F1	1,692	$241.39	$408K

Holdings After Transaction: Ordinary Shares — 6,832 shares (Direct)

Footnotes (1)

F1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Key Figures

Shares disposed for tax withholding: 1,706 shares Smaller tax-withholding lot: 14 shares at $244.0643 per share Larger tax-withholding lot: 1,692 shares at $241.3900 per share +2 more

5 metrics

Shares disposed for tax withholding 1,706 shares Total ordinary shares delivered or withheld on August 31, 2026 to satisfy tax obligations from RSU vesting

Smaller tax-withholding lot 14 shares at $244.0643 per share Code F disposition on August 31, 2026 for payment of tax liability

Larger tax-withholding lot 1,692 shares at $241.3900 per share Code F disposition on August 31, 2026 for payment of tax liability

Transactions coded as payment of tax liability 2 transactions Both non-derivative, code F, tax-withholding dispositions on August 31, 2026

Exercise price or tax liability shares count 1,706 shares Aggregate shares associated with code F events in the transaction summary

Key Terms

restricted stock units, Rule 10b5-1, tax obligations, payment of tax liability by delivering or withholding securities

4 terms

restricted stock units financial

"tax obligations arising out of the vesting of previously granted restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Rule 10b5-1 regulatory

"document-level indicator for Rule 10b5-1 plans is marked false"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

tax obligations financial

"Shares sold to satisfy tax obligations arising out of the vesting"

payment of tax liability by delivering or withholding securities financial

"transaction code F is described as payment of tax liability by delivering or withholding securities"

FAQ

What insider transaction did JAZZ director Laura Hamill report?

Director Laura Hamill reported two dispositions of ordinary shares on August 31, 2026, totaling 1,706 shares, to satisfy tax obligations related to the vesting of previously granted restricted stock units.

Were the JAZZ insider transactions open-market sales?

No. The filing states that the 1,706 shares were sold to satisfy tax obligations from the vesting of restricted stock units, indicating tax-withholding dispositions rather than discretionary open-market sales.

How many JAZZ shares did the director dispose of to cover RSU taxes?

In total, 1,706 ordinary shares of Jazz Pharmaceuticals were delivered or withheld on August 31, 2026 to cover tax obligations arising from the vesting of previously granted restricted stock units.

Was a Rule 10b5-1 trading plan involved in these JAZZ transactions?

No. The document-level indicator for Rule 10b5-1 plans is marked false, meaning these reported tax-withholding dispositions were not affirmed as made under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 09/02/2026 - 05:24 PM Accepted by SEC EDGAR 09/02/2026 - 05:24 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hamill Laura

(Last)

(First)

(Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City)

(State)

(Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	08/31/2026		F⁽¹⁾		14	D	$244.0643	8,524	D
Ordinary Shares	08/31/2026		F⁽¹⁾		1,692	D	$241.39	6,832	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

	By: /s/Paz Dizon, as attorney in fact For: Laura Jean Hamill	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR